OCULAR THERAPEUTIX, INC - OCUL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | See Remarks | G | A | 50,092.0 | 0.0 | 0.0 | 50,092.0 | View | |
| Jun 18, 2026 | See Remarks | G | D | 50,092.0 | 0.0 | 0.0 | 2,547,078.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 100,464.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 64,000.0 | View | |
| Jun 12, 2026 | Chief Financial Officer | A | A | 14,024.0 | 0.0 | 0.0 | 14,024.0 | View | |
| Jun 12, 2026 | Chief Financial Officer | A | A | 15,441.0 | 0.0 | 0.0 | 68,097.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 60,933.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 260,933.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 60,933.0 | View | |
| Jun 12, 2026 | — | A | A | 44,000.0 | 0.0 | 0.0 | 44,000.0 | View | |
| Jun 12, 2026 | — | A | A | 14,000.0 | 0.0 | 0.0 | 65,433.0 | View | |
| Jun 05, 2026 | Chief Medical Officer | S | D | 14,828.0 | 8.27 | 122,627.56 | 300,079.0 | View | |
| May 28, 2026 | See Remarks | G | A | 394,696.0 | 0.0 | 0.0 | 694,811.0 | View | |
| May 28, 2026 | See Remarks | G | D | 394,696.0 | 0.0 | 0.0 | 0.0 | View | |
| May 28, 2026 | See Remarks | S | D | 21,156.0 | 8.2 | 173,479.2 | 2,597,170.0 | View | |
| May 28, 2026 | Chief Development Officer | S | D | 2,967.0 | 8.2 | 24,329.4 | 266,141.0 | View | |
| May 28, 2026 | Chief Scientific Officer | S | D | 3,018.0 | 8.2 | 24,747.6 | 320,350.0 | View | |
| May 28, 2026 | Chief Strategy Officer | S | D | 1,858.0 | 8.2 | 15,235.6 | 328,795.0 | View | |
| Apr 13, 2026 | See Remarks | G | A | 394,696.0 | 0.0 | 0.0 | 394,696.0 | View | |
| Apr 13, 2026 | See Remarks | G | D | 394,696.0 | 0.0 | 0.0 | 2,618,326.0 | View | |
| Feb 25, 2026 | Chief Scientific Officer | S | D | 3,057.0 | 8.28 | 25,311.96 | 323,368.0 | View | |
| Feb 25, 2026 | Chief Development Officer | S | D | 2,810.0 | 8.28 | 23,266.8 | 269,108.0 | View | |
| Feb 25, 2026 | See Remarks | S | D | 20,056.0 | 8.28 | 166,063.68 | 3,013,022.0 | View | |
| Feb 25, 2026 | Chief Strategy Officer | S | D | 1,759.0 | 8.28 | 14,564.52 | 330,653.0 | View | |
| Feb 24, 2026 | Chief Medical Officer | S | D | 3,510.0 | 7.74 | 27,167.4 | 314,907.0 | View | |
| Feb 24, 2026 | — | P | A | 60,229.0 | 7.66 | 461,354.14 | 246,933.0 | View | |
| Feb 17, 2026 | Chief Medical Officer | S | D | 7,863.0 | 9.04 | 71,081.52 | 318,417.0 | View | |
| Feb 17, 2026 | See Remarks | S | D | 124,882.0 | 9.04 | 1,128,933.28 | 3,033,078.0 | View | |
| Feb 17, 2026 | Chief Strategy Officer | S | D | 10,348.0 | 9.04 | 93,545.92 | 332,412.0 | View | |
| Feb 17, 2026 | Chief Operating Officer | S | D | 11,446.0 | 9.04 | 103,471.84 | 366,356.0 | View | |
| Feb 04, 2026 | Chief Operating Officer | S | D | 6,035.0 | 8.54 | 51,538.9 | 377,802.0 | View | |
| Feb 04, 2026 | Chief Operating Officer | S | D | 5,455.0 | 9.14 | 49,858.7 | 383,837.0 | View | |
| Jan 26, 2026 | Global CCO | A | A | 416,000.0 | 0.0 | 0.0 | 416,000.0 | View | |
| Jan 26, 2026 | Global CCO | A | A | 136,000.0 | 0.0 | 0.0 | 136,000.0 | View | |
| Jan 22, 2026 | Interim CFO | A | A | 33,000.0 | 0.0 | 0.0 | 33,000.0 | View |